ZTS
$70.79
Zoetis Inc Class A
$.38
.54%
ZTS
Earnings Whisper ®
N/A
4th Quarter December 2017
Consensus:  $0.66
Revenue:  $1.41 Bil
Thursday
Feb 1
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, November 02, 2017

What do you expect when ZTS reports earnings?
Beat
Meet
Miss

Where is ZTS's stock price going from here?
Up
Flat
Down
Stock chart of ZTS
Analysts
Summary of analysts' recommendations for ZTS
Score
Grade
Pivots
Resistance
$72.07
$71.60
$71.19

$70.72

Support
$70.31
$69.84
$69.43
Tweet
Growth
Description
Zoetis Inc. is an animal health company. The company discovers, develops, manufactures and markets veterinary vaccines and medicines with a focus on both farm and companion animals. It primarily operates in the United States, Europe, Africa, the Middle East, Canada, Latin America, and the Asia Pacific. Zoetis Inc. is based in Madison, United States.
Peers
CelgeneRegeneron PharmaceuticalsBioMarin PharmaceuticalVertex PharmaceuticalsJohnson & JohnsonUltragenyx PharmaceuticalEndo International plcInterCeptEli LillyBristol-Myers Squibb